Shanghai Yizhong Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Yizhong Pharmaceutical has a total shareholder equity of CN¥1.5B and total debt of CN¥53.1M, which brings its debt-to-equity ratio to 3.5%. Its total assets and total liabilities are CN¥1.6B and CN¥116.8M respectively. Shanghai Yizhong Pharmaceutical's EBIT is CN¥125.8M making its interest coverage ratio -3.7. It has cash and short-term investments of CN¥1.3B.
Key information
3.5%
Debt to equity ratio
CN¥53.10m
Debt
Interest coverage ratio | -3.7x |
Cash | CN¥1.28b |
Equity | CN¥1.50b |
Total liabilities | CN¥116.81m |
Total assets | CN¥1.62b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688091's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥112.5M).
Long Term Liabilities: 688091's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥4.3M).
Debt to Equity History and Analysis
Debt Level: 688091 has more cash than its total debt.
Reducing Debt: 688091's debt to equity ratio has increased from 0% to 3.5% over the past 5 years.
Debt Coverage: 688091's debt is well covered by operating cash flow (161.2%).
Interest Coverage: 688091 earns more interest than it pays, so coverage of interest payments is not a concern.